Skip to main content
Adjuvant olaparib yields survival benefit in HER2-negative BRCA1/2 breast cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Adjuvant olaparib yields survival benefit in HER2-negative BRCA1/2 breast cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
0.91
Breast
0
0.75
Cancer
0
0.45
Chemotherapy
0
0.3
Neoadjuvant Therapy
0
0.3
Grant
0
0.15
Travel Medicine
0
0.15
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Family Medicine/Primary Care
0
0.97
Public Health & Prevention
0
0.88
Ob/Gyn & Women's Health
0
0.75
Infectious Diseases
0
0.67
Edit Tags